12-19439990-A-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_153207.5(AEBP2):āc.291A>Cā(p.Glu97Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,522,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153207.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AEBP2 | NM_153207.5 | c.291A>C | p.Glu97Asp | missense_variant | 1/8 | ENST00000266508.14 | NP_694939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP2 | ENST00000266508.14 | c.291A>C | p.Glu97Asp | missense_variant | 1/8 | 1 | NM_153207.5 | ENSP00000266508 | ||
AEBP2 | ENST00000398864.7 | c.291A>C | p.Glu97Asp | missense_variant | 1/9 | 1 | ENSP00000381840 | P1 | ||
AEBP2 | ENST00000538425.5 | c.-16-22520A>C | intron_variant | 4 | ENSP00000444255 | |||||
AEBP2 | ENST00000541908.5 | c.-16-22520A>C | intron_variant | 3 | ENSP00000437983 |
Frequencies
GnomAD3 genomes AF: 0.00000664 AC: 1AN: 150548Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000808 AC: 1AN: 123688Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67314
GnomAD4 exome AF: 0.0000109 AC: 15AN: 1371910Hom.: 0 Cov.: 35 AF XY: 0.00000591 AC XY: 4AN XY: 677262
GnomAD4 genome AF: 0.00000664 AC: 1AN: 150548Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.291A>C (p.E97D) alteration is located in exon 1 (coding exon 1) of the AEBP2 gene. This alteration results from a A to C substitution at nucleotide position 291, causing the glutamic acid (E) at amino acid position 97 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at